385 related articles for article (PubMed ID: 12939122)
21. The effect of caffeine, green tea and tyrosine on thermogenesis and energy intake.
Belza A; Toubro S; Astrup A
Eur J Clin Nutr; 2009 Jan; 63(1):57-64. PubMed ID: 17882140
[TBL] [Abstract][Full Text] [Related]
22. Effect of herbal Ephedra sinica and Evodia rutaecarpa on body composition and resting metabolic rate: a randomized, double-blind clinical trial in Korean premenopausal women.
Kim HJ; Park JM; Kim JA; Ko BP
J Acupunct Meridian Stud; 2008 Dec; 1(2):128-38. PubMed ID: 20633465
[TBL] [Abstract][Full Text] [Related]
23. Thermogenic ingredients and body weight regulation.
Hursel R; Westerterp-Plantenga MS
Int J Obes (Lond); 2010 Apr; 34(4):659-69. PubMed ID: 20142827
[TBL] [Abstract][Full Text] [Related]
24. Use of nonprescription dietary supplements for weight loss is common among Americans.
Blanck HM; Serdula MK; Gillespie C; Galuska DA; Sharpe PA; Conway JM; Khan LK; Ainsworth BE
J Am Diet Assoc; 2007 Mar; 107(3):441-7. PubMed ID: 17324663
[TBL] [Abstract][Full Text] [Related]
25. Effect of hypocaloric diet plus sibutramine treatment on hormonal and metabolic features in overweight and obese women with polycystic ovary syndrome: a randomized, 24-week study.
Florakis D; Diamanti-Kandarakis E; Katsikis I; Nassis GP; Karkanaki A; Georgopoulos N; Panidis D
Int J Obes (Lond); 2008 Apr; 32(4):692-9. PubMed ID: 18071341
[TBL] [Abstract][Full Text] [Related]
26. Targeting energy expenditure in muscle as a means of combating obesity.
Clarke IJ; Henry BA
Clin Exp Pharmacol Physiol; 2010 Jan; 37(1):121-4. PubMed ID: 19650796
[TBL] [Abstract][Full Text] [Related]
27. Use of sibutramine in overweight adult hispanic patients with type 2 diabetes mellitus: a 12-month, randomized, double-blind, placebo-controlled clinical trial.
Sánchez-Reyes L; Fanghänel G; Yamamoto J; Martínez-Rivas L; Campos-Franco E; Berber A
Clin Ther; 2004 Sep; 26(9):1427-35. PubMed ID: 15531005
[TBL] [Abstract][Full Text] [Related]
28. Multinutrient supplement containing ephedra and caffeine causes weight loss and improves metabolic risk factors in obese women: a randomized controlled trial.
Hackman RM; Havel PJ; Schwartz HJ; Rutledge JC; Watnik MR; Noceti EM; Stohs SJ; Stern JS; Keen CL
Int J Obes (Lond); 2006 Oct; 30(10):1545-56. PubMed ID: 16552410
[TBL] [Abstract][Full Text] [Related]
29. Neuropeptide Y in obese women during treatment with adrenergic modulation drugs.
Zahorska-Markiewicz B; Obuchowicz E; Waluga M; Tkacz E; Herman ZS
Med Sci Monit; 2001; 7(3):403-8. PubMed ID: 11386016
[TBL] [Abstract][Full Text] [Related]
30. Comparison of the effects of sibutramine and orlistat on obese, poorly-controlled type 2 diabetic patients.
Chou KM; Huang BY; Fanchiang JK; Chen CH
Chang Gung Med J; 2007; 30(6):538-46. PubMed ID: 18350737
[TBL] [Abstract][Full Text] [Related]
31. Effect of a proprietary Magnolia and Phellodendron extract on weight management: a pilot, double-blind, placebo-controlled clinical trial.
Garrison R; Chambliss WG
Altern Ther Health Med; 2006; 12(1):50-4. PubMed ID: 16454147
[TBL] [Abstract][Full Text] [Related]
32. A randomized double-blind placebo-controlled clinical trial of a product containing ephedrine, caffeine, and other ingredients from herbal sources for treatment of overweight and obesity in the absence of lifestyle treatment.
Coffey CS; Steiner D; Baker BA; Allison DB
Int J Obes Relat Metab Disord; 2004 Nov; 28(11):1411-9. PubMed ID: 15356670
[TBL] [Abstract][Full Text] [Related]
33. Effect of orlistat on weight regain and cardiovascular risk factors following a very-low-energy diet in abdominally obese patients: a 3-year randomized, placebo-controlled study.
Richelsen B; Tonstad S; Rössner S; Toubro S; Niskanen L; Madsbad S; Mustajoki P; Rissanen A
Diabetes Care; 2007 Jan; 30(1):27-32. PubMed ID: 17192328
[TBL] [Abstract][Full Text] [Related]
34. Efficacy and safety of ephedra and ephedrine for weight loss and athletic performance: a meta-analysis.
Shekelle PG; Hardy ML; Morton SC; Maglione M; Mojica WA; Suttorp MJ; Rhodes SL; Jungvig L; Gagné J
JAMA; 2003 Mar; 289(12):1537-45. PubMed ID: 12672771
[TBL] [Abstract][Full Text] [Related]
35. Long-term maintenance of weight loss with sibutramine in a GP setting following a specialist guided very-low-calorie diet: a double-blind, placebo-controlled, parallel group study.
Mathus-Vliegen EM;
Eur J Clin Nutr; 2005 Aug; 59 Suppl 1():S31-8; discussion S39. PubMed ID: 16052193
[TBL] [Abstract][Full Text] [Related]
36. The effect of ephedra and high fat dieting: a cause for concern! A case report.
Fleming RM
Angiology; 2007; 58(1):102-5. PubMed ID: 17351165
[TBL] [Abstract][Full Text] [Related]
37. Sibutramine plus meal replacement therapy for body weight loss and maintenance in obese patients.
Early JL; Apovian CM; Aronne LJ; Fernstrom MH; Frank A; Greenway FL; Heber D; Kushner RF; Cwik KM; Walch JK; Hewkin AC; Blakesley V
Obesity (Silver Spring); 2007 Jun; 15(6):1464-72. PubMed ID: 17557984
[TBL] [Abstract][Full Text] [Related]
38. High protein diets decrease total and abdominal fat and improve CVD risk profile in overweight and obese men and women with elevated triacylglycerol.
Clifton PM; Bastiaans K; Keogh JB
Nutr Metab Cardiovasc Dis; 2009 Oct; 19(8):548-54. PubMed ID: 19179060
[TBL] [Abstract][Full Text] [Related]
39. Caffeine-herbal ephedra combination increases resting energy expenditure, heart rate and blood pressure.
Vukovich MD; Schoorman R; Heilman C; Jacob P; Benowitz NL
Clin Exp Pharmacol Physiol; 2005; 32(1-2):47-53. PubMed ID: 15730434
[TBL] [Abstract][Full Text] [Related]
40. Safety and efficacy of citrus aurantium for weight loss.
Bent S; Padula A; Neuhaus J
Am J Cardiol; 2004 Nov; 94(10):1359-61. PubMed ID: 15541270
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
